Product Code: GVR-4-68040-052-0
U.S. Dietary Supplements Market Growth & Trends:
The U.S. dietary supplements market size is expected to reach USD 78.94 billion by 2030, growing at a CAGR of 5.7% during the forecast period, according to a new report by Grand View Research, Inc. The dietary supplement market in the U.S. is growing rapidly due to several key factors. Increasing health awareness among consumers has led to a higher demand for vitamins, minerals, and other supplements aimed at maintaining and improving overall well-being. The aging population is also a significant driver; as older adults are more inclined to use supplements to manage age-related health issues. Rising healthcare costs have prompted many people to seek preventive measures, including dietary supplements, to avoid expensive medical treatments.
Additionally, there is a strong trend of preventive health care, with individuals focusing on boosting their immune systems and preventing chronic diseases through supplementation. The market has also benefited from increased availability and aggressive marketing through various channels such as online platforms, health stores, and pharmacies. Innovations in technology and research have resulted in new and more effective supplement formulations tailored to specific health needs.
Regulatory support in the U.S. has allowed a broad range of products to be marketed and sold, provided they meet safety and labeling standards. The COVID-19 pandemic further increased awareness about immune health, leading to a surge in demand for immune-boosting supplements like vitamins C and D, and zinc. These factors collectively contribute to the robust growth of the dietary supplement market in the U.S.
As per the Consumer Survey on Dietary Supplements conducted by the Council for Responsible Nutrition in 2022, the dietary supplement industry is thriving and firmly integrated into mainstream culture. The survey indicates that a substantial 75% of Americans have reported using dietary supplements within the last year. The survey reveals a growing trend in specialty supplements, with over half of supplement users acknowledging their use of specialty supplements in the past year. Among these specialty supplements, the most favored options include omega-3s, probiotics, melatonin, and fiber.
U.S. Dietary Supplements Market Report Highlights:
- In terms of application-end user, adults in the energy and weight management segment accounted for a revenue share of 67.5% in 2023. Adults in the U.S. are becoming more aware of the role supplements play in maintaining good health and preventing chronic diseases. Growing awareness of health and fitness further propels adults to invest in supplements that enhance physical performance, manage stress, and support metabolic health, which are often challenging to maintain through diet and exercise alone.
- In terms of application-ingredient, vitamins in the energy and weight management segment is expected to grow at the fastest CAGR from 2024 to 2030. Americans consume vitamin supplements for energy and weight management to boost energy levels and support metabolic processes. Additionally, these supplements fill nutritional gaps that may be present in the diet, ensuring adequate intake of essential vitamins. This enhanced energy and metabolic support ultimately improve physical performance and weight management efforts.
- Based on form, the tablets segment dominated the market in 2023. Owing to their convenient design, tablets protect active ingredients from light, moisture, and oxygen, ensuring potency and quality are preserved over time. This feature extends shelf-life, making tablets a preferred choice for consumers.
- Based on type, the OTC (Over-the-Counter) segment dominated the market with a revenue share of 76.0% in 2023. OTC supplements are often more affordable than prescription supplements, making them an attractive option for consumers
- Based on distribution channel, the offline distribution channel dominated the market with a revenue share of 78.0% in 2023. Consumer preference to physically see and purchase products, immediate availability for purchase, trust in established brands, and ability to receive personalized recommendations from store staff, are some of the reasons for offline purchase of dietary supplements in the U.S.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Sources & Third-Party Perspectives
- 1.3.4. Primary Research
- 1.4. Information Analysis
- 1.4.1. Data Analysis Models
- 1.5. Market Information & Data Visualization
- 1.6. Data Validation & Publishing
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segmental Outlook
- 2.3. Regional Outlook
Chapter 3. U.S. Dietary Supplement Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.2. Industry Value Chain Analysis
- 3.2.1. Raw Distribution Channel Outlook
- 3.2.2. Manufacturing & Technology Outlook
- 3.2.3. Profit Margin Analysis
- 3.3. Market Dynamics
- 3.3.1. Market Driver Analysis
- 3.3.2. Market Restraint Analysis
- 3.3.3. Market Opportunities
- 3.3.4. Market Challenges
- 3.4. Industry Analysis - Porter's Five Forces Analysis
- 3.5. Market Entry Strategies
Chapter 4. U.S. Dietary Supplement Market: Application-End User Estimates & Trend Analysis
- 4.1. Application-End User Movement Analysis & Market Share, 2023 & 2030
- 4.2. Energy & Weight Management
- 4.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.2.1.1. Adults
- 4.2.1.1.1. Male
- 4.2.1.1.2. Female
- 4.2.1.2. Geriatric
- 4.2.1.3. Pregnant Women
- 4.2.1.4. Children
- 4.2.1.5. Infants
- 4.3. General Health
- 4.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.3.1.1. Adults
- 4.3.1.1.1. Male
- 4.3.1.1.2. Female
- 4.3.1.2. Geriatric
- 4.3.1.3. Pregnant Women
- 4.3.1.4. Children
- 4.3.1.5. Infants
- 4.4. Bone & Joint Health
- 4.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.4.1.1. Adults
- 4.4.1.1.1. Male
- 4.4.1.1.2. Female
- 4.4.1.2. Geriatric
- 4.4.1.3. Pregnant Women
- 4.4.1.4. Children
- 4.4.1.5. Infants
- 4.5. Gastrointestinal Health
- 4.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.5.1.1. Adults
- 4.5.1.1.1. Male
- 4.5.1.1.2. Female
- 4.5.1.2. Geriatric
- 4.5.1.3. Pregnant Women
- 4.5.1.4. Children
- 4.5.1.5. Infants
- 4.6. Immunity
- 4.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.6.1.1. Adults
- 4.6.1.1.1. Male
- 4.6.1.1.2. Female
- 4.6.1.2. Geriatric
- 4.6.1.3. Pregnant Women
- 4.6.1.4. Children
- 4.6.1.5. Infants
- 4.7. Cardiac Health
- 4.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.7.1.1. Adults
- 4.7.1.1.1. Male
- 4.7.1.1.2. Female
- 4.7.1.2. Geriatric
- 4.7.1.3. Pregnant Women
- 4.7.1.4. Children
- 4.7.1.5. Infants
- 4.8. Anti-Cancer
- 4.8.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.8.1.1. Adults
- 4.8.1.1.1. Male
- 4.8.1.1.2. Female
- 4.8.1.2. Geriatric
- 4.8.1.3. Pregnant Women
- 4.8.1.4. Children
- 4.8.1.5. Infants
- 4.9. Diabetes
- 4.9.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.9.1.1. Adults
- 4.9.1.1.1. Male
- 4.9.1.1.2. Female
- 4.9.1.2. Geriatric
- 4.9.1.3. Pregnant Women
- 4.9.1.4. Children
- 4.9.1.5. Infants
- 4.10. Lung Detox/Cleanse
- 4.10.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.10.1.1. Adults
- 4.10.1.1.1. Male
- 4.10.1.1.2. Female
- 4.10.1.2. Geriatric
- 4.10.1.3. Pregnant Women
- 4.10.1.4. Children
- 4.10.1.5. Infants
- 4.11. Skin/Hair/Nails
- 4.11.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.11.1.1. Adults
- 4.11.1.1.1. Male
- 4.11.1.1.2. Female
- 4.11.1.2. Geriatric
- 4.11.1.3. Pregnant Women
- 4.11.1.4. Children
- 4.11.1.5. Infants
- 4.12. Sexual Health
- 4.12.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.12.1.1. Adults
- 4.12.1.1.1. Male
- 4.12.1.1.2. Female
- 4.12.1.2. Geriatric
- 4.12.1.3. Pregnant Women
- 4.12.1.4. Children
- 4.12.1.5. Infants
- 4.13. Brain/Mental Health
- 4.13.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.13.1.1. Adults
- 4.13.1.1.1. Male
- 4.13.1.1.2. Female
- 4.13.1.2. Geriatric
- 4.13.1.3. Pregnant Women
- 4.13.1.4. Children
- 4.13.1.5. Infants
- 4.14. Insomnia
- 4.14.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.14.1.1. Adults
- 4.14.1.1.1. Male
- 4.14.1.1.2. Female
- 4.14.1.2. Geriatric
- 4.14.1.3. Pregnant Women
- 4.14.1.4. Children
- 4.14.1.5. Infants
- 4.15. Menopause
- 4.15.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.15.1.1. Adults
- 4.15.1.1.1. Male
- 4.15.1.1.2. Female
- 4.15.1.2. Geriatric
- 4.15.1.3. Pregnant Women
- 4.15.1.4. Children
- 4.15.1.5. Infants
- 4.16. Anti-Aging
- 4.16.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.16.1.1. Adults
- 4.16.1.1.1. Male
- 4.16.1.1.2. Female
- 4.16.1.2. Geriatric
- 4.16.1.3. Pregnant Women
- 4.16.1.4. Children
- 4.16.1.5. Infants
- 4.17. Prenatal Health
- 4.17.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.17.1.1. Adults
- 4.17.1.1.1. Male
- 4.17.1.1.2. Female
- 4.17.1.2. Geriatric
- 4.17.1.3. Pregnant Women
- 4.17.1.4. Children
- 4.17.1.5. Infants
- 4.18. Others
- 4.18.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.18.1.1. Adults
- 4.18.1.1.1. Male
- 4.18.1.1.2. Female
- 4.18.1.2. Geriatric
- 4.18.1.3. Pregnant Women
- 4.18.1.4. Children
- 4.18.1.5. Infants
Chapter 5. U.S. Dietary Supplement Market: Application-ingredients Estimates & Trend Analysis
- 5.1. Application-ingredients Movement Analysis & Market Share, 2023 & 2030
- 5.2. Energy & Weight Management
- 5.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.2.1.1. Vitamins
- 5.2.1.2. Botanicals
- 5.2.1.3. Minerals
- 5.2.1.4. Protein & Amino Acids
- 5.2.1.4.1. Collagen
- 5.2.1.4.2. Others
- 5.2.1.5. Fibers & Specialty Carbohydrates
- 5.2.1.6. Omega Fatty Acids
- 5.2.1.7. Probiotics
- 5.2.1.8. Others
- 5.3. General Health
- 5.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.3.1.1. Vitamins
- 5.3.1.2. Botanicals
- 5.3.1.3. Minerals
- 5.3.1.4. Protein & Amino Acids
- 5.3.1.4.1. Collagen
- 5.3.1.4.2. Others
- 5.3.1.5. Fibers & Specialty Carbohydrates
- 5.3.1.6. Omega Fatty Acids
- 5.3.1.7. Probiotics
- 5.3.1.8. Others
- 5.4. Bone & Joint Health
- 5.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.4.1.1. Vitamins
- 5.4.1.2. Botanicals
- 5.4.1.3. Minerals
- 5.4.1.4. Protein & Amino Acids
- 5.4.1.4.1. Collagen
- 5.4.1.4.2. Others
- 5.4.1.5. Fibers & Specialty Carbohydrates
- 5.4.1.6. Omega Fatty Acids
- 5.4.1.7. Probiotics
- 5.4.1.8. Others
- 5.5. Gastrointestinal Health
- 5.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.5.1.1. Vitamins
- 5.5.1.2. Botanicals
- 5.5.1.3. Minerals
- 5.5.1.4. Protein & Amino Acids
- 5.5.1.4.1. Collagen
- 5.5.1.4.2. Others
- 5.5.1.5. Fibers & Specialty Carbohydrates
- 5.5.1.6. Omega Fatty Acids
- 5.5.1.7. Probiotics
- 5.5.1.8. Others
- 5.6. Immunity
- 5.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.6.1.1. Vitamins
- 5.6.1.2. Botanicals
- 5.6.1.3. Minerals
- 5.6.1.4. Protein & Amino Acids
- 5.6.1.4.1. Collagen
- 5.6.1.4.2. Others
- 5.6.1.5. Fibers & Specialty Carbohydrates
- 5.6.1.6. Omega Fatty Acids
- 5.6.1.7. Probiotics
- 5.6.1.8. Others
- 5.7. Cardiac Health
- 5.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.7.1.1. Vitamins
- 5.7.1.2. Botanicals
- 5.7.1.3. Minerals
- 5.7.1.4. Protein & Amino Acids
- 5.7.1.4.1. Collagen
- 5.7.1.4.2. Others
- 5.7.1.5. Fibers & Specialty Carbohydrates
- 5.7.1.6. Omega Fatty Acids
- 5.7.1.7. Probiotics
- 5.7.1.8. Others
- 5.8. Anti-Cancer
- 5.8.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.8.1.1. Vitamins
- 5.8.1.2. Botanicals
- 5.8.1.3. Minerals
- 5.8.1.4. Protein & Amino Acids
- 5.8.1.4.1. Collagen
- 5.8.1.4.2. Others
- 5.8.1.5. Fibers & Specialty Carbohydrates
- 5.8.1.6. Omega Fatty Acids
- 5.8.1.7. Probiotics
- 5.8.1.8. Others
- 5.9. Diabetes
- 5.9.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.9.1.1. Vitamins
- 5.9.1.2. Botanicals
- 5.9.1.3. Minerals
- 5.9.1.4. Protein & Amino Acids
- 5.9.1.4.1. Collagen
- 5.9.1.4.2. Others
- 5.9.1.5. Fibers & Specialty Carbohydrates
- 5.9.1.6. Omega Fatty Acids
- 5.9.1.7. Probiotics
- 5.9.1.8. Others
- 5.10. Lung Detox/Cleanse
- 5.10.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.10.1.1. Vitamins
- 5.10.1.2. Botanicals
- 5.10.1.3. Minerals
- 5.10.1.4. Protein & Amino Acids
- 5.10.1.4.1. Collagen
- 5.10.1.4.2. Others
- 5.10.1.5. Fibers & Specialty Carbohydrates
- 5.10.1.6. Omega Fatty Acids
- 5.10.1.7. Probiotics
- 5.10.1.8. Others
- 5.11. Skin/Hair/Nails
- 5.11.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.11.1.1. Vitamins
- 5.11.1.2. Botanicals
- 5.11.1.3. Minerals
- 5.11.1.4. Protein & Amino Acids
- 5.11.1.4.1. Collagen
- 5.11.1.4.2. Others
- 5.11.1.5. Fibers & Specialty Carbohydrates
- 5.11.1.6. Omega Fatty Acids
- 5.11.1.7. Probiotics
- 5.11.1.8. Others
- 5.12. Sexual Health
- 5.12.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.12.1.1. Vitamins
- 5.12.1.2. Botanicals
- 5.12.1.3. Minerals
- 5.12.1.4. Protein & Amino Acids
- 5.12.1.4.1. Collagen
- 5.12.1.4.2. Others
- 5.12.1.5. Fibers & Specialty Carbohydrates
- 5.12.1.6. Omega Fatty Acids
- 5.12.1.7. Probiotics
- 5.12.1.8. Others
- 5.13. Brain/Mental Health
- 5.13.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.13.1.1. Vitamins
- 5.13.1.2. Botanicals
- 5.13.1.3. Minerals
- 5.13.1.4. Protein & Amino Acids
- 5.13.1.4.1. Collagen
- 5.13.1.4.2. Others
- 5.13.1.5. Fibers & Specialty Carbohydrates
- 5.13.1.6. Omega Fatty Acids
- 5.13.1.7. Probiotics
- 5.13.1.8. Others
- 5.14. Insomnia
- 5.14.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.14.1.1. Vitamins
- 5.14.1.2. Botanicals
- 5.14.1.3. Minerals
- 5.14.1.4. Protein & Amino Acids
- 5.14.1.4.1. Collagen
- 5.14.1.4.2. Others
- 5.14.1.5. Fibers & Specialty Carbohydrates
- 5.14.1.6. Omega Fatty Acids
- 5.14.1.7. Probiotics
- 5.14.1.8. Others
- 5.15. Menopause
- 5.15.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.15.1.1. Vitamins
- 5.15.1.2. Botanicals
- 5.15.1.3. Minerals
- 5.15.1.4. Protein & Amino Acids
- 5.15.1.4.1. Collagen
- 5.15.1.4.2. Others
- 5.15.1.5. Fibers & Specialty Carbohydrates
- 5.15.1.6. Omega Fatty Acids
- 5.15.1.7. Probiotics
- 5.15.1.8. Others
- 5.16. Anti-Aging
- 5.16.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.16.1.1. Vitamins
- 5.16.1.2. Botanicals
- 5.16.1.3. Minerals
- 5.16.1.4. Protein & Amino Acids
- 5.16.1.4.1. Collagen
- 5.16.1.4.2. Others
- 5.16.1.5. Fibers & Specialty Carbohydrates
- 5.16.1.6. Omega Fatty Acids
- 5.16.1.7. Probiotics
- 5.16.1.8. Others
- 5.17. Prenatal Health
- 5.17.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.17.1.1. Vitamins
- 5.17.1.2. Botanicals
- 5.17.1.3. Minerals
- 5.17.1.4. Protein & Amino Acids
- 5.17.1.4.1. Collagen
- 5.17.1.4.2. Others
- 5.17.1.5. Fibers & Specialty Carbohydrates
- 5.17.1.6. Omega Fatty Acids
- 5.17.1.7. Probiotics
- 5.17.1.8. Others
- 5.18. Others
- 5.18.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.18.1.1. Vitamins
- 5.18.1.2. Botanicals
- 5.18.1.3. Minerals
- 5.18.1.4. Protein & Amino Acids
- 5.18.1.4.1. Collagen
- 5.18.1.4.2. Others
- 5.18.1.5. Fibers & Specialty Carbohydrates
- 5.18.1.6. Omega Fatty Acids
- 5.18.1.7. Probiotics
- 5.18.1.8. Others
Chapter 6. U.S. Dietary Supplement Market: Form Estimates & Trend Analysis
- 6.1. Form Movement Analysis & Market Share, 2023 & 2030
- 6.2. Tablets
- 6.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3. Capsules
- 6.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4. Soft Gels
- 6.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.5. Powders
- 6.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.6. Gummies
- 6.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.7. Liquids
- 6.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.8. Others
- 6.8.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 7. U.S. Dietary Supplement Market: Type Estimates & Trend Analysis
- 7.1. Type Movement Analysis & Market Share, 2023 & 2030
- 7.2. OTC
- 7.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3. Prescribed
- 7.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 8. U.S. Dietary Supplement Market: Distribution Channel Estimates & Trend Analysis
- 8.1. Distribution Channel Movement Analysis & Market Share, 2023 & 2030
- 8.2. Offline
- 8.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.2.1.1. Hypermarkets/Supermarkets
- 8.2.1.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.2.1.2. Pharmacies
- 8.2.1.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.2.1.3. Specialty Stores
- 8.2.1.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.2.1.4. Practioners
- 8.2.1.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.2.1.5. Others
- 8.2.1.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.3. Online
- 8.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 9. Competitive Analysis
- 9.1. Recent developments & impact analysis, by key market participants
- 9.2. Company Categorization
- 9.3. Participant's Overview
- 9.4. Financial Performance
- 9.5. Application-End User Benchmarking
- 9.6. Company Market Share Analysis, 2023 (%)
- 9.7. Company Heat Map Analysis
- 9.8. Strategy Mapping
- 9.9. Company Profiles
- 9.9.1. Amway
- 9.9.1.1 Company Overview
- 9.9.1.2 Financial Performance
- 9.9.1.3 Application-End User Benchmarking
- 9.9.1.4 Strategic Initiatives
- 9.9.2. Abbott
- 9.9.2.1 Company Overview
- 9.9.2.2 Financial Performance
- 9.9.2.3 Application-End User Benchmarking
- 9.9.2.4 Strategic Initiatives
- 9.9.3. Bayer AG
- 9.9.3.1 Company Overview
- 9.9.3.2 Financial Performance
- 9.9.3.3 End User Portfolios
- 9.9.3.4 Strategic Initiatives
- 9.9.4. Glanbia plc
- 9.9.4.1 Company Overview
- 9.9.4.2 Financial Performance
- 9.9.4.3 Application-End User Benchmarking
- 9.9.4.4 Strategic Initiatives
- 9.9.5. Pfizer, Inc.
- 9.9.5.1 Company Overview
- 9.9.5.2 Financial Performance
- 9.9.5.3 Application-End User Benchmarking
- 9.9.5.4 Strategic Initiatives
- 9.9.6. Archer Daniels Midland
- 9.9.6.1 Company Overview
- 9.9.6.2 Financial Performance
- 9.9.6.3 Application-End User Benchmarking
- 9.9.6.4 Strategic Initiatives
- 9.9.7. GlaxoSmithKline plc
- 9.9.7.1 Company Overview
- 9.9.7.2 Financial Performance
- 9.9.7.3 End User Portfolios
- 9.9.8. NU SKIN
- 9.9.8.1 Company Overview
- 9.9.8.2 Financial Performance
- 9.9.8.3 Application-End User Benchmarking
- 9.9.8.4 Strategic Initiatives
- 9.9.9. Herbalife Nutrition
- 9.9.9.1 Company Overview
- 9.9.9.2 Financial Performance
- 9.9.9.3 Application-End User Benchmarking
- 9.9.9.4 Strategic Initiatives
- 9.9.10. Nature's Sunshine Products, Inc.
- 9.9.10.1 Company Overview
- 9.9.10.2 Financial Performance
- 9.9.10.3 Application-End User Benchmarking
- 9.9.10.4 Strategic Initiatives
- 9.9.11. DuPont de Nemours Inc.
- 9.9.11.1 Company Overview
- 9.9.11.2 Financial Performance
- 9.9.11.3 Application-End User Benchmarking
- 9.9.11.4 Strategic Initiatives
- 9.9.12. NOW Foods
- 9.9.12.1 Company Overview
- 9.9.12.2 Financial Performance
- 9.9.12.3 Application-End User Benchmarking
- 9.9.12.4 Strategic Initiatives